Inspire Medical Systems, Inc.
Company Stats
- Market Cap
- $2.0B
- as of Sep 30, 2026
- Shares Outstanding
- 28.9M
- Free Float
- 92.6%
Income Statement
- Revenue
- $912.0M
- Operating Income
- $51.0M
- Net Income
- $145.4M
- EBITDA
- $64.9M
- Revenue Growth, 3Y
- 30.8%
- FCF Margin, 3Y Avg
- 6.7%
- FCF Margin, Worst Year
- 0.2%
Cash Flow
- Free Cash Flow
- $78.5M
- FCF Yield
- 3.9%
- Owner FCF Yield
- -2.6%
Balance Sheet
- Cash & Equivalents
- $104.8M
Returns & Capital
- Share Repurchases
- $175.0M
- Buyback Yield, 3Y Avg
- 2.9%
- SBC, 3Y Avg
- $109.6M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $912.0M | $78.5M | 8.6% |
| FY2024 | $802.8M | $91.1M | 11.4% |
| FY2023 | $624.8M | $1.0M | 0.2% |
| FY2022 | $407.9M | $2.5M | 0.6% |
| FY2021 | $233.4M | -$24.8M | -10.6% |
Annual filing data through FY ended December 31, 2025; shares and float as of November 1, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Earnings
Other Coverage
October 14, 2026
Theme Survey
GLP-1 companies reshape access and detail treatment dropouts
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground
GLP-1 companies reshape access and detail treatment dropouts
September 28, 2026
QBook
Stronger demand supports expansion as pricing diverges
August 14, 2026
Industry Earnings Roundup
Healthcare Earnings: Demand Surges, Costs Bite Back
August 4, 2026
Theme Survey
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground